UK probes genetic link between obesity drugs and pancreas damage

The U.K. is asking patients whose pancreas became dangerously inflamed after taking obesity drugs like Wegovy and Zepbound to come in for tests to understand whether there’s a genetic risk for the condition.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup